Počet záznamov: 1
registrácia lieku
SYS d017277 LBL 00000cz--a2200000o--4500 005 20250606213429.0 008 920520|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 $a BA006 065 $a E05.290.250 065 $a E05.337.300 065 $a I01.880.604.605.250.250 066 $a 01 $c 03 150 $a registrácia lieku $x EC $x HI $x LJ $x MT $x OG $2 slo 450 $w v $a Drug Approval Process $2 eng 450 $w v $a New Drug Approval $2 eng 450 $w v $a schvaľovanie lieku $2 slo 450 $w v $a proces schvaľovania nových liekov $2 slo 550 $7 sllk_us_auth*d002986 $Y Clinical Trials as Topic $w b $a skúšanie klinické ako téma 550 $7 sllk_us_auth*d015507 $Y Drugs, Investigational $w p $a lieky skúšané 550 $7 sllk_us_auth*d056687 $Y Off-Label Use $w b $a použitie lieku mimo schválených indikácií 665 $a 93 $2 eng 680 9-
$i Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug. $2 eng 680 $a by govt regulatory agency, U.S. (not restricted to FDA) or foreign $2 eng 750 -2
$a Drug Approval $2 eng 980 $x M
Počet záznamov: 1